(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ONCOCAL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ONCOCAL

ST13

US500000079155613

Class

5

Filing

79155613

Registration

4910739

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

07/09/2023

Trademark type

Word

Nice classes

5

Filing date

10/13/2014

Registration date

03/08/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/23/2022

Last transaction

10/28/2022

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

AU

Examiner

SAKAI, HAN

Law office

L60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

OncoSil Medical Ltd

Representatives

Christina M. Licursi Wolf, Greenfield & Sacks, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of cancer for use in connection with brachytherapy; Veterinary preparations for cancer for use in connection with brachytherapy

Publications

History of USPTO decisions and trademark events.

38 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

07/09/2023

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

06/22/2023

INPC

INVALIDATION PROCESSED

06/22/2023

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

05/23/2023

C71T

CANCELLED SECTION 71

09/23/2022

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

03/08/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

07/15/2016

FICS

FINAL DISPOSITION NOTICE SENT TO IB

06/28/2016

FIMP

FINAL DISPOSITION PROCESSED

06/28/2016

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/08/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

03/08/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/22/2015

PUBO

PUBLISHED FOR OPPOSITION

12/22/2015

GPNX

NOTIFICATION PROCESSED BY IB

12/18/2015

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/02/2015

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

12/02/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/02/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/08/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/08/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/08/2015

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

10/08/2015

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

09/08/2015

GNFR

FINAL REFUSAL E-MAILED

09/08/2015

CNFR

FINAL REFUSAL WRITTEN

09/08/2015

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/19/2015

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/19/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/01/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/31/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/31/2015

RFNT

REFUSAL PROCESSED BY IB

02/20/2015

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/04/2015

RFRR

REFUSAL PROCESSED BY MPU

02/04/2015

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

02/04/2015

CNRT

NON-FINAL ACTION WRITTEN

02/03/2015

DOCK

ASSIGNED TO EXAMINER

02/02/2015

MAFR

APPLICATION FILING RECEIPT MAILED

12/05/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/01/2014

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/27/2014

Continuous trademark protection

Get notified about every new filing that threatens ONCOCAL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.